WallStreetZenWallStreetZen

NASDAQ: IRMD
Iradimed Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IRMD

Based on 1 analyst offering 12 month price targets for Iradimed Corp

Min Forecast
$116.00+40.55%
Avg Forecast
$116.00+40.55%
Max Forecast
$116.00+40.55%

Should I buy or sell IRMD stock?

Based on 1 analyst offering ratings for Iradimed Corp.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IRMD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IRMD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their IRMD stock forecasts and price targets.

IRMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-02

1 of 1

Forecast return on equity

Is IRMD forecast to generate an efficient return?

Company
N/A
Industry
22.17%
Market
168.87%

Forecast return on assets

Is IRMD forecast to generate an efficient return on assets?

Company
N/A
Industry
13.69%

IRMD earnings per share forecast

What is IRMD's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$2.13+17.13%
Avg 2 year Forecast
$2.36+29.74%
Avg 3 year Forecast
$2.76+51.88%
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

IRMD revenue forecast

What is IRMD's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$93.1M+7.86%
Avg 2 year Forecast
$102.9M+19.2%
Avg 3 year Forecast
$115.1M+33.27%
IRMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IRMD earnings growth forecast

How is IRMD forecast to perform vs Medical Devices companies and vs the US market?

Company
14.44%
Industry
22.04%
Market
31.19%
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

IRMD revenue growth forecast

How is IRMD forecast to perform vs Medical Devices companies and vs the US market?

Company
9.89%
Industry
7.24%
Market
13.54%
IRMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IRMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IRMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
IRMD$82.53$116.00+40.55%Strong Buy
ENOV$18.22$38.63+111.99%Strong Buy
LMRI$11.39$13.00+14.14%Strong Buy
BVS$13.16$16.00+21.58%Strong Buy
TNDM$16.81$27.04+60.87%Buy
View Top Medical Device Stocks

Iradimed Stock Forecast FAQ

Is Iradimed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IRMD) stock is to Strong Buy IRMD stock.

Out of 1 analyst, 1 (100%) are recommending IRMD as a Strong Buy, 0 (0%) are recommending IRMD as a Buy, 0 (0%) are recommending IRMD as a Hold, 0 (0%) are recommending IRMD as a Sell, and 0 (0%) are recommending IRMD as a Strong Sell.

If you're new to stock investing, here's how to buy Iradimed stock.

What is IRMD's earnings growth forecast for 2026-2028?

(NASDAQ: IRMD) Iradimed's forecast annual earnings growth rate of 14.44% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.19%.

Iradimed's earnings in 2026 is $23,054,610.On average, 4 Wall Street analysts forecast IRMD's earnings for 2026 to be $27,259,307, with the lowest IRMD earnings forecast at $26,190,315, and the highest IRMD earnings forecast at $28,061,052. On average, 4 Wall Street analysts forecast IRMD's earnings for 2027 to be $30,193,922, with the lowest IRMD earnings forecast at $27,944,690, and the highest IRMD earnings forecast at $32,223,217.

In 2028, IRMD is forecast to generate $35,345,801 in earnings, with the lowest earnings forecast at $33,959,691 and the highest earnings forecast at $36,385,383.

What is IRMD's revenue growth forecast for 2026-2028?

(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 9.89% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Iradimed's revenue in 2026 is $86,338,963.On average, 4 Wall Street analysts forecast IRMD's revenue for 2026 to be $1,190,801,324, with the lowest IRMD revenue forecast at $1,142,850,108, and the highest IRMD revenue forecast at $1,227,167,526. On average, 4 Wall Street analysts forecast IRMD's revenue for 2027 to be $1,316,037,114, with the lowest IRMD revenue forecast at $1,253,125,118, and the highest IRMD revenue forecast at $1,366,801,468.

In 2028, IRMD is forecast to generate $1,471,271,184 in revenue, with the lowest revenue forecast at $1,413,473,985 and the highest revenue forecast at $1,514,491,214.

What is IRMD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IRMD) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.69%.

What is IRMD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IRMD price target, the average IRMD price target is $116.00, with the highest IRMD stock price forecast at $116.00 and the lowest IRMD stock price forecast at $116.00.

The Wall Street analyst predicted that Iradimed's share price could reach $116.00 by Apr 2, 2027. The average Iradimed stock price prediction forecasts a potential upside of 40.55% from the current IRMD share price of $82.53.

What is IRMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IRMD) Iradimed's current Earnings Per Share (EPS) is $1.82. On average, analysts forecast that IRMD's EPS will be $2.13 for 2026, with the lowest EPS forecast at $2.05, and the highest EPS forecast at $2.19. On average, analysts forecast that IRMD's EPS will be $2.36 for 2027, with the lowest EPS forecast at $2.19, and the highest EPS forecast at $2.52. In 2028, IRMD's EPS is forecast to hit $2.76 (min: $2.66, max: $2.85).

What is IRMD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IRMD) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.